Antibody To Lutzomyia Longiapalpis Sand Fly Midgut Protein (LuloPer1): A Novel Leishmania Transmission Blocking Vaccine Read more about Antibody To Lutzomyia Longiapalpis Sand Fly Midgut Protein (LuloPer1): A Novel Leishmania Transmission Blocking Vaccine US Application 61/256,250Filed on 2009-10-29
Neutralizing Antibodies Against HIV-1 And Their Use Read more about Neutralizing Antibodies Against HIV-1 And Their Use US Application 61/252,613Filed on 2009-10-16
Unique Method For Designing Expandable HIV Mosaic Vaccines To Allow For Improved Response To Newly Identified Epitopes Read more about Unique Method For Designing Expandable HIV Mosaic Vaccines To Allow For Improved Response To Newly Identified Epitopes US Application 61/252,545Filed on 2009-10-16
Mechanisms For Protection Against Pandemic Strains Of Influenza Read more about Mechanisms For Protection Against Pandemic Strains Of Influenza US Application 61/248,835Filed on 2009-10-05
Neutralizing Antibodies to HIV-1 and Their Use Read more about Neutralizing Antibodies to HIV-1 and Their Use US Application 61/246,039Filed on 2009-09-25
RSV Immunogens, Antibodies and Compositions Thereof Read more about RSV Immunogens, Antibodies and Compositions Thereof US Application 61/253,826Filed on 2009-10-21
Discovery Of Potential Antimalarial Drugs Read more about Discovery Of Potential Antimalarial Drugs US Application 61/237,417Filed on 2009-08-27
Methods Of Use And Compositions For The Diagnosis And Treatment Of Infectious Disease Read more about Methods Of Use And Compositions For The Diagnosis And Treatment Of Infectious Disease US Application 60/381,220Filed on 2002-05-17
Use Ixolaris, A Tissue Factor (Anticoagulant) Inhibitor, For The Treatment Of Cancer Read more about Use Ixolaris, A Tissue Factor (Anticoagulant) Inhibitor, For The Treatment Of Cancer US Application 61/225,961Filed on 2009-07-16
GARP (LRRC32) is Essential for the Surface Expression of Latent TGF-B Read more about GARP (LRRC32) is Essential for the Surface Expression of Latent TGF-B US Application 61/185,933Filed on 2009-06-10